For both A549 and MDA-MB-231, elevated CD47 levels have been reported and are considered to be a driver for metastasis for the respective tumor type (non-small cell lung cancer [NSCLC], A549 cells; triple-negative breast cancer, MDA-MB-231 cells).23 Here, CD47 is linked to non-small cell lung carcinoma.